The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Anvitoff     4-(aminomethyl)cyclohexane-1- carboxylic acid

Synonyms: Transamin, Exacyl, Ugurol, AMCHA, Cyklokapron, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cyklokapron


High impact information on Cyklokapron


Chemical compound and disease context of Cyklokapron


Biological context of Cyklokapron


Anatomical context of Cyklokapron


Associations of Cyklokapron with other chemical compounds


Gene context of Cyklokapron


Analytical, diagnostic and therapeutic context of Cyklokapron


  1. Antifibrinolytic treatment in subarachnoid hemorrhage. Vermeulen, M., Lindsay, K.W., Murray, G.D., Cheah, F., Hijdra, A., Muizelaar, J.P., Schannong, M., Teasdale, G.M., van Crevel, H., van Gijn, J. N. Engl. J. Med. (1984) [Pubmed]
  2. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia. Sabbà, C., Gallitelli, M., Palasciano, G. N. Engl. J. Med. (2001) [Pubmed]
  3. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. Sindet-Pedersen, S., Ramström, G., Bernvil, S., Blombäck, M. N. Engl. J. Med. (1989) [Pubmed]
  4. Cimetidine and tranexamic acid in the treatment of acute upper-gastrointestinal-tract bleeding. Barer, D., Ogilvie, A., Henry, D., Dronfield, M., Coggon, D., French, S., Ellis, S., Atkinson, M., Langman, M. N. Engl. J. Med. (1983) [Pubmed]
  5. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura. Endo, Y., Nishimura, S., Miura, A. JAMA (1988) [Pubmed]
  6. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. Sperzel, M., Huetter, J. J. Thromb. Haemost. (2007) [Pubmed]
  7. Cimetidine and tranexamic acid for upper-gastrointestinal-tract bleeding. Chalmers, T.C. N. Engl. J. Med. (1983) [Pubmed]
  8. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. Hattori, N., Degen, J.L., Sisson, T.H., Liu, H., Moore, B.B., Pandrangi, R.G., Simon, R.H., Drew, A.F. J. Clin. Invest. (2000) [Pubmed]
  9. Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits. Vaughan, D.E., Declerck, P.J., De Mol, M., Collen, D. J. Clin. Invest. (1989) [Pubmed]
  10. Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors. Hedner, U., Kisiel, W. J. Clin. Invest. (1983) [Pubmed]
  11. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation. Kikuchi, Y., Kizawa, I., Oomori, K., Miyauchi, M., Kita, T., Sugita, M., Tenjin, Y., Kato, K. Cancer Res. (1987) [Pubmed]
  12. Tranexamic acid: a review of its use in the management of menorrhagia. Wellington, K., Wagstaff, A.J. Drugs (2003) [Pubmed]
  13. von Willebrand disease and women's health. Lee, C.A., Abdul-Kadir, R. Semin. Hematol. (2005) [Pubmed]
  14. Experimental study of the influence of endoleak size on pressure in the aneurysm sac and the consequences of thrombosis. Schurink, G.W., Aarts, N.J., Van Baalen, J.M., Kool, L.J., Van Bockel, J.H. The British journal of surgery. (2000) [Pubmed]
  15. Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid. Asakura, H., Sano, Y., Yoshida, T., Omote, M., Ontachi, Y., Mizutani, T., Yamazaki, M., Morishita, E., Takami, A., Miyamoto, K., Nakao, S. Intensive care medicine. (2004) [Pubmed]
  16. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Horrow, J.C., Van Riper, D.F., Strong, M.D., Brodsky, I., Parmet, J.L. Circulation (1991) [Pubmed]
  17. Streptokinase-induced platelet aggregation. Prevalence and mechanism. Vaughan, D.E., Van Houtte, E., Declerck, P.J., Collen, D. Circulation (1991) [Pubmed]
  18. Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Brouwers, P.J., Dippel, D.W., Vermeulen, M., Lindsay, K.W., Hasan, D., van Gijn, J. Stroke (1993) [Pubmed]
  19. Chronic pulmonary thromboembolism in dogs treated with tranexamic acid. Moser, K.M., Cantor, J.P., Olman, M., Villespin, I., Graif, J.L., Konopka, R., Marsh, J.J., Pedersen, C. Circulation (1991) [Pubmed]
  20. Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage. Patchett, S.E., O'Donoghue, D.P. Gut (1995) [Pubmed]
  21. Cell proliferation within Bowman's capsule in mice. Morley, A.R., Wheeler, J. J. Pathol. (1985) [Pubmed]
  22. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): Regulation of ALK-1/endoglin pathway in endothelial cells. Fernandez-L, A., Garrido-Martin, E.M., Sanz-Rodriguez, F., Ramirez, J.R., Morales-Angulo, C., Zarrabeitia, R., Perez-Molino, A., Bernabéu, C., Botella, L.M. Thromb. Haemost. (2007) [Pubmed]
  23. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene. Fay, W.P., Parker, A.C., Condrey, L.R., Shapiro, A.D. Blood (1997) [Pubmed]
  24. Tranexamic acid: a review of its use in surgery and other indications. Dunn, C.J., Goa, K.L. Drugs (1999) [Pubmed]
  25. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. Longstaff, C., Gaffney, P.J. Biochemistry (1991) [Pubmed]
  26. The relationship between inhibition of plasminogen-activator activity and prostatic involution. Rennie, P.S., Bowden, J.F., Bruchovsky, N., Cheng, H. Biochem. J. (1988) [Pubmed]
  27. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation. Petersen, L.C., Brender, J., Suenson, E. Biochem. J. (1985) [Pubmed]
  28. Differential effects of aprotinin and tranexamic acid on endotoxin desensitization of blood cells induced by circulation through an isolated extracorporeal circuit. Asehnoune, K., Dehoux, M., Leçon-Malas, V., Toueg, M.L., Gonieaux, M.H., Omnes, L., Desmonts, J.M., Durand, G., Philip, I. J. Cardiothorac. Vasc. Anesth. (2002) [Pubmed]
  29. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis. Ronday, H.K., Smits, H.H., Quax, P.H., van der Pluijm, G., Löwik, C.W., Breedveld, F.C., Verheijen, J.H. Br. J. Rheumatol. (1997) [Pubmed]
  30. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid. Mathews, I.I., Vanderhoff-Hanaver, P., Castellino, F.J., Tulinsky, A. Biochemistry (1996) [Pubmed]
  31. Binding of tissue-type plasminogen activator to human melanoma cells. Bizik, J., Stephens, R.W., Grofova, M., Vaheri, A. J. Cell. Biochem. (1993) [Pubmed]
  32. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters. Yoshioka, A., Kamitsuji, H., Takase, T., Iida, Y., Tsukada, S., Mikami, S., Fukui, H. Haemostasis (1982) [Pubmed]
  33. Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy. Wu, C.C., Ho, W.M., Cheng, S.B., Yeh, D.C., Wen, M.C., Liu, T.J., P'eng, F.K. Ann. Surg. (2006) [Pubmed]
  34. Tranexamic acid in subarachnoid hemorrhage. A double-blind study. Kaste, M., Ramsay, M. Stroke (1979) [Pubmed]
  35. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Hijdra, A., van Gijn, J., Nagelkerke, N.J., Vermeulen, M., van Crevel, H. Stroke (1988) [Pubmed]
WikiGenes - Universities